Home NDC 0006-0267 MAXALT
Product NDC 0006-0267
11-digit product format 000060267
Labeler code 0006
Product ID 0006-0267_27f96f39-58fb-422e-ba80-be074e98fc07
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name rizatriptan benzoate
Dosage form TABLET
Route ORAL
Labeler Merck Sharp & Dohme Corp.
Application NDA020864
Marketing category NDA
Marketing start 1998-06-29
Marketing end 0000-00-00
Substance RIZATRIPTAN BENZOATE
Active strength 10 mg/1
Pharmacologic classes Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0006-0267-18 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0006-0267-18 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0006-0267-18 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0006-0267-18 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0006-0267-18 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0006-0267-18 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0006-0267-18 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0006-0267-18 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0006-0267-18 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0006-0267-18 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0006-0267-18 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0006-0267-18 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020864-001 MAXALT RIZATRIPTAN BENZOATE EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 N020864-002 MAXALT RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020864-002 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020864-001 MAXALT EQ 5MG BASE TABLET / ORAL RLD 1998-06-29 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020864-001 MAXALT EQ 5MG BASE TABLET / ORAL RLD 1998-06-29 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 1998-06-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020864-001 MAXALT EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-06-29 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N020864-002 MAXALT EQ 10MG BASE TABLET / ORAL AB RLD, RS 1998-06-29 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded rizatriptan benzoate ACTIVE INGREDIENT WR978S7QHH MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 rizatriptan ACTIVE MOIETY 51086HBW8G MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 aspartame INACTIVE INGREDIENT Z0H242BBR1 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 gelatin INACTIVE INGREDIENT 2G86QN327L MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 glycine INACTIVE INGREDIENT TE7660XO1C MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 magnesium stearate INACTIVE INGREDIENT 70097M6I30 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 mannitol INACTIVE INGREDIENT 3OWL53L36A MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] 21 RIZATRIPTAN BENZOATE ACTIVE INGREDIENT WR978S7QHH MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 rizatriptan benzoate ACTIVE INGREDIENT WR978S7QHH MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 rizatriptan ACTIVE MOIETY 51086HBW8G MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 RIZATRIPTAN ACTIVE MOIETY 51086HBW8G MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 aspartame INACTIVE INGREDIENT Z0H242BBR1 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 gelatin INACTIVE INGREDIENT 2G86QN327L MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 GLYCINE INACTIVE INGREDIENT TE7660XO1C MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 glycine INACTIVE INGREDIENT TE7660XO1C MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 magnesium stearate INACTIVE INGREDIENT 70097M6I30 MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 MANNITOL INACTIVE INGREDIENT 3OWL53L36A MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 mannitol INACTIVE INGREDIENT 3OWL53L36A MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING MAXALT (RIZATRIPTAN BENZOATE) TABLET [STAT RX USA LLC] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.] 2 rizatriptan benzoate ACTIVE INGREDIENT WR978S7QHH MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 rizatriptan ACTIVE MOIETY 51086HBW8G MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MAXALT (RIZATRIPTAN BENZOATE) TABLET [REBEL DISTRIBUTORS CORP] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MAXALT RIZATRIPTAN BENZOATE Organon LLC 007b4644-e0e7-4863-9ae3-fe09676b3f5f 2026-01-29 Warnings, Adverse reactions Exact identifier application applno (NDA): 020864 application number: NDA020864
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0006-0267-18 00006026718 18 POUCH in 1 CARTON (0006-0267-18) > 1 TABLET in 1 POUCH (0006-0267-01) 18 pouch 1998-06-29 0000-00-00 No No Current